Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 1;2(1):86-89.
doi: 10.34067/KID.0006102020. eCollection 2021 Jan 28.

SARS-CoV-2 in Spent Dialysate from Chronic Peritoneal Dialysis Patients with COVID-19

Affiliations

SARS-CoV-2 in Spent Dialysate from Chronic Peritoneal Dialysis Patients with COVID-19

Xiaoling Wang et al. Kidney360. .

Abstract

Background: To date, it is unclear whether SARS-CoV-2 is present in spent dialysate from patients with COVID-19 on peritoneal dialysis (PD). Our aim was to assess the presence or absence of SARS-CoV-2 in spent dialysate from patients on chronic PD who had a confirmed diagnosis of COVID-19.

Methods: Spent PD dialysate samples from patients on PD who were positive for COVID-19 were collected between March and August 2020. The multiplexed, real-time RT-PCR assay contained primer/probe sets specific to different SARS-CoV-2 genomic regions and to bacteriophage MS2 as an internal process control for nucleic acid extraction. Demographic and clinical data were obtained from patients' electronic health records.

Results: A total of 26 spent PD dialysate samples were collected from 11 patients from ten dialysis centers. Spent PD dialysate samples were collected, on average, 25±13 days (median, 20; range, 10-45) after the onset of symptoms. The temporal distance of PD effluent collection relative to the closest positive nasal-swab RT-PCR result was 15±11 days (median, 14; range, 1-41). All 26 PD effluent samples tested negative at three SARS-CoV-2 genomic regions.

Conclusions: Our findings indicate the absence of SARS-CoV-2 in spent PD dialysate collected at ≥10 days after the onset of COVID-19 symptoms. We cannot rule out the presence of SARS-CoV-2 in spent PD dialysate in the early stage of COVID-19.

Keywords: COVID-19; RT-PCR; SARS-CoV-2; chronic kidney disease; dialysis; dialysis solutions; peritoneal dialysis.

PubMed Disclaimer

Conflict of interest statement

J.E. Chao, G.F. Dias, N. Grobe, M. Hakim, M. Han, O. Thwin, Z. Haq, P. Kotanko, A. Patel, P. Preciado, J. Raimann, X. Tao, L. Tisdale, X. Wang, and X. Ye are employees of the Renal Research Institute, a wholly owned subsidiary of FMCNA. D. Chatoth and R. Lasky are employees of FMCNA. D. Chatoth and P. Kotanko hold stock in Fresenius Medical Care. All remaining authors have nothing to disclose.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
All PDE samples tested negative for SARS-CoV-2 RNA after 40 cycles of RT-PCR amplification. Day 0 indicates the onset of symptoms of coronavirus disease 2019. Triangles indicate nasopharyngeal-swab dates; squares indicate time points when peritoneal dialysis effluent (PDE) samples were received and processed. Red triangles indicate a positive nasopharyngeal-swab test result; blue triangles indicate negative nasopharyngeal-swab test results. Blue squares indicate negative PDE test results. NS, nasopharyngeal-swab; RT-PCR, real-time RT-PCR.

References

    1. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W: Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 323: 1843–1844, 2020. 10.1001/jama.2020.3786 - DOI - PMC - PubMed
    1. Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, Wang YY, Xiao GF, Yan B, Shi ZL, Zhou P: Molecular and serological investigation of 2019-nCoV infected patients: Implication of multiple shedding routes. Emerg Microbes Infect 9: 386–389, 2020. 10.1080/22221751.2020.1729071 - DOI - PMC - PubMed
    1. Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, Men D, Huang Q, Liu Y, Yang B, Ding J, Li F: Detectable serum severe acute respiratory syndrome-coronavirus 2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus 2019. Clin Infect Dis 71: 1937–1942, 2020 - PMC - PubMed
    1. Hagman K, Hedenstierna M, Gille-Johnson P, Hammas B, Grabbe M, Dillner J, Ursing J: SARS-CoV-2 RNA in serum as predictor of severe outcome in COVID-19: A retrospective cohort study [published online ahead of print August 28, 2020]. Clin Infect Dis - PMC - PubMed
    1. Farzadegan H, Ford D, Malan M, Masters B, Scheel PJ Jr: HIV-1 survival kinetics in peritoneal dialysis effluent. Kidney Int 50: 1659–1662, 1996. 10.1038/ki.1996.482 - DOI - PubMed

Substances